Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm

Circulation Research

Volumn 102, Issue 11, 2008, Pages 1368-1377

  Tsuruda, Toshihiro ^a,c   Kato, Johji ^a   Hatakeyama, Kinta ^a   Kojima, Kazushi ^a   Yano, Mitsuhiro ^a   Yano, Yoshikazu ^a   Nakamura, Kunihide ^a   Nakamura Uchiyama, Fukumi ^b   Matsushima, Yoshibumi ^a   Imamura, Takuroh ^a   Onitsuka, Toshio ^a   Asada, Yujiro ^a   Nawa, Yukifumi ^b   Eto, Tanenao ^a   Kitamura, Kazuo ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adventitia; Aneurysm; Inflammation; Mast cell; Matrix metalloproteinase

Indexed keywords

APOLIPOPROTEIN E; CALCIUM CHLORIDE; ELASTIN; GELATINASE; GELATINASE B; STEM CELL FACTOR; TRANILAST; TRYPTASE; ANTHRANILIC ACID DERIVATIVE;

ABDOMINAL AORTA ANEURYSM; ADVENTITIA; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTERY DIAMETER; ARTERY DILATATION; ARTERY MEDIA; ARTICLE; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CONNECTIVE TISSUE; DEGRANULATION; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; RAT STRAIN;

ANIMALS; ANTHRANILIC ACIDS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; CALCIUM CHLORIDE; CELL COUNT; CELL DEGRANULATION; CELLS, CULTURED; CONNECTIVE TISSUE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; MAST CELLS; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; RATS; RATS, MUTANT STRAINS; T-LYMPHOCYTES;

EID: 44949085653     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.173682     Document Type: Article

References (44)

1. Kadoglou NP, Liapis CD. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin. 2004;20:419-432.
2. Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, Loftus I, Thompson MM. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg. 2005;30:227-244.
3. Hallett JWJ. Management of abdominal aortic aneurysms. Mayo Clin Proc. 2000;75:395-399.
4. Anidjar S, Dobrin PB, Eichorst M, Graham GP, Chejfec G. Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg. 1992;16:139-147.
5. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625-632.
6. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15: 1145-1151.
7. Xiong W, Zhao Y, Prall A, Greiner TC, Baxter BT. Key roles of CD4 + T cells and IFN-γ in the development of abdominal aortic aneurysms in a murine model. J Immunol. 2004;172:2607-2612.
8. Eliason JL, Hannawa KK, Ailawadi G, Sinha I, Ford JW, Deogracias MP, Roelofs KJ, Woodrum DT, Ennis TL, Henke PK, Stanley JC, Thompson RW, Upchurch GRJ. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation. 2005;112:232-240.
9. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol. 2004;114:21-27.
10. Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol Biol. 2006;315:13-34.
11. von Stebut E, Metz M, Milon G, Knop J, Maurer M. Early macrophage influx to sites of cutaneous granuloma formation is dependent MIP-1 α/(β released from neutrophils recruited by mast cell-derived TNFα. Blood. 2003;101:210-215.
12. Henz BM, Maurer M, Lippert U, Worm M, Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol. 2001;10:1-10.
13. Nishida M, Uchikawa R, Tegoshi T, Yamada M, Matsuda S, Hyoh Y, Arizono N. Migration of neutrophils is dependent on mast cells in nonspecific pleurisy in rats. APMIS. 1999;107:929-936.
14. Atkinson JB, Harlan CW, Harlan GC, Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol. 1994;25:154-159.
15. Leskinen M, Wang Y, Leszczynski D, Lindstedt KA, Kovanen PT. Mast cell chymase induces apoptosis of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:516-522.
16. Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem. 2005; 280:9291-9296.
17. Tsujimura T, Hirota S, Nomura S, Niwa Y, Yamazaki M, Tono T, Morii E, Kim HM, Kondo K, Nishimune Y, Kitamura Y. Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene. Blood. 1991;78:1942-1946.
18. Tei H, Kasugai T, Tsujimura T, Adachi S, Furitsu T, Tohya K, Kimura M, Zsebo KM, Newlands GF, Miller HR, Kanakura Y, Kitamura Y. Characterization of cultured mast cells derived from Ws/Ws mast cell-deficient rats with a small deletion at tyrosine kinase domain of c-kit. Blood. 1994;83:916-925.
19. Matsushima Y, Hayashi S, Tachibana M. Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency. Mamm Genome. 1999;10:352-357.
20. Matsushima Y, Sakurai T, Ohoka A, Ohnuki T, Tada N, Asoh Y, Tachibana M. Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J Atheroscler Thromb. 2001;8:71-79.
21. Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S, Libby P, Mac-Farlane LA, Mallen-St Clair J, Shi GP. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med. 2007;13:719-724.
22. Sun J, Sukhova GK, Yang M, Wolters PJ, Macfarlane LA, Libby P, Sun C, Zhang Y, Liu J, Ennis TL, Knispel R, Xiong W, Thompson RW, Baxter BT, Shi GP. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest. 2007;117: 3359-3368.
23. Bot I, de Jager SC, Zernecke A, Lindstedt KA, van Berkel TJ, Weber C, Biessen EA. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation. 2007;115:2516-2525.
24. Ocana E, Bohorquezb J, Pérez-Requenac J, Brieva JA, Rodríguez C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis. 2003;170:39-48.
25. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci U S A. 2005;102:6467-6472.
26. Wei YF, Heghinian K, Bell RL, Jakschik BA. Contribution of macrophages to immediate hypersensitivity reaction. J Immunol. 1986;137: 1993-2000.
27. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, Mekori YA. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α. J Immunol. 2001;167:4008-4016.
28. Lohi J, Harvima I, Keski-Oja J. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem. 1992; 50:337-349.
29. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995;96:318-326.
30. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004;110:16 -21.
31. Takagi H, Umemoto T. Smoking promotes pathogenesis of aortic aneu-rysm through the 5-lipoxygenase pathway. Med Hypotheses. 2005;64: 1117-1119.
32. Zhao L, Moos MPW, Gräbner R, Pédrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lötzer K, Huang L, Cui J, Rader DJ, Evans JF, Habenicht AJR, Funk CD. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med. 2004;10: 966-973.
33. Thompson MM, Jones L, Nasim A, Sayers RD, Bell PR. Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 1996;11: 464-469.
34. Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol. 1997; 150:993-1007.
35. Hiromatsu Y, Toda S. Mast cells and angiogenesis. Microsc Res Tech. 2003;60:64-69.
36. Petersen E, Gineitis A, Wågberg F, Á ngquist K-A. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture. Eur J Vasc Endovasc Surg. 2000;20:457-461.
37. Niwa Y, Kasugai T, Ohno K, Morimoto M, Yamazaki M, Dohmae K, Nishimune Y, Kondo K, Kitamura Y. Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. Blood. 1991;78:1936-1941.
38. Komatsu H, Kojima M, Tsutsumi N, Hamano S, Kusama H, Ujiie A, Ikeda S, Nakazawa M. Study of the mechanism of inhibitory action of tranilast on chemical mediator release. Jpn J Pharmacol. 1988;46:43-51.
39. Ikai K, Ujihara M, Fujii K, Urade Y. Inhibitory effect of tranilast on prostaglandin D synthetase. Biochem Pharmacol. 1989;38:2673-2676.
40. Fukuyama J, Ichikawa K, Hamano S, Shibata N. Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet. Eur J Pharmacol. 1996;318:327-332.
41. Shimizu T, Kanai K, Kyo Y, Asano K, Hisamitsu T, Suzaki H. Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro. J Pharm Pharmacol. 2006;58:91-99.
42. Fukui D, Miyagawa S, Soeda J, Tanaka K, Urayama H, Kawasaki S. Overexpression of transforming growth factor beta1 in smooth muscle cells of human abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2003;25:540-545.
43. Olsson N, Piek E, ten Dijke P, Nilsson G. Human mast cell migration in response to members of the transforming growth factor-β family. J Leukoc Biol. 2000;67:350-356.
44. Ward MR, Sasahara T, Agrotis A, Dilley RJ, Jennings GL, Bobik A. Inhibitory effects of tranilast on expression of transforming growth factor-β isoforms and receptors in injured arteries. Atherosclerosis. 1998; 137:267-275.